Stock Analysts’ updated eps estimates for Monday, May 18th:
Addus HomeCare (NASDAQ:ADUS) had its market outperform rating reaffirmed by analysts at Citizens Jmp. The firm currently has a $142.00 price target on the stock.
Aebi Schmidt (NASDAQ:AEBI) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $15.00 price target on the stock.
AJ Bell (LON:AJB) had its buy rating reaffirmed by analysts at UBS Group AG. They currently have a GBX 630 target price on the stock.
Amrize (NYSE:AMRZ) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $65.00 price target on the stock.
Auction Technology Group (LON:ATG) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 460 target price on the stock.
Auto Trader Group (LON:AUTO) had its sell rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a GBX 470 price target on the stock.
Aviva (LON:AV) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a GBX 770 target price on the stock.
Brunswick (NYSE:BC) had its neutral rating reaffirmed by analysts at DA Davidson. They currently have a $76.00 target price on the stock.
British Land (LON:BLND) had its neutral rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a GBX 440 price target on the stock.
Burberry Group (LON:BRBY) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 1,480 price target on the stock.
Boston Scientific (NYSE:BSX) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $80.00 target price on the stock.
Boston Scientific (NYSE:BSX) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $77.00 price target on the stock.
BlackRock Long-Term Municipal Advantage Trust’s (LON:BTA) had its sell rating reissued by analysts at UBS Group AG. The firm currently has a GBX 175 target price on the stock.
Close Brothers Group (LON:CBG) had its buy rating reaffirmed by analysts at UBS Group AG. The firm currently has a GBX 555 target price on the stock.
CG Oncology (NASDAQ:CGON) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $100.00 price target on the stock.
CoreWeave (NASDAQ:CRWV) had its neutral rating reaffirmed by analysts at DA Davidson. The firm currently has a $100.00 price target on the stock, down from their previous price target of $175.00.
ConvaTec Group (LON:CTEC) had its buy rating reaffirmed by analysts at UBS Group AG. They currently have a GBX 375 price target on the stock.
Citius Pharmaceuticals (NASDAQ:CTXR) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $4.00 price target on the stock.
DHI Group (NYSE:DHX) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $10.00 target price on the stock.
Expedia Group (NASDAQ:EXPE) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $330.00 price target on the stock.
Experian (LON:EXPN) had its buy rating reiterated by analysts at UBS Group AG. UBS Group AG currently has a GBX 3,700 target price on the stock.
easyJet (LON:EZJ) had its buy rating reissued by analysts at UBS Group AG. They currently have a GBX 635 target price on the stock.
Future (LON:FUTR) had its hold rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 330 target price on the stock.
Grafton Group (LON:GFTU) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 1,275 price target on the stock.
Great Portland Estates (LON:GPE) had its sell rating reissued by analysts at UBS Group AG. UBS Group AG currently has a GBX 315 target price on the stock.
Hiscox (LON:HSX) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 1,850 price target on the stock.
Intermediate Capital Group (LON:ICG) had its neutral rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a GBX 2,150 target price on the stock.
MiNK Therapeutics (NASDAQ:INKT) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $35.00 price target on the stock.
Invivyd (NASDAQ:IVVD) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $10.00 price target on the stock.
Krystal Biotech (NASDAQ:KRYS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $310.00 price target on the stock.
Legend Biotech (NASDAQ:LEGN) had its buy rating reissued by analysts at HC Wainwright. They currently have a $50.00 target price on the stock.
Littelfuse (NASDAQ:LFUS) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $520.00 price target on the stock.
Manx Financial Group (LON:MFX) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.
Marks and Spencer Group (LON:MKS) had its buy rating reissued by analysts at UBS Group AG. The firm currently has a GBX 425 price target on the stock.
MetaVia (NASDAQ:MTVA) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $20.00 target price on the stock.
Netflix (NASDAQ:NFLX) had its buy rating reiterated by analysts at Bank of America Corporation. Bank of America Corporation currently has a $125.00 target price on the stock.
Nurix Therapeutics (NASDAQ:NRIX) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $30.00 price target on the stock.
NVIDIA (NASDAQ:NVDA) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $300.00 target price on the stock.
Oruka Therapeutics (NASDAQ:ORKA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $120.00 price target on the stock.
Oncobiologics (NASDAQ:OTLK) had its neutral rating reaffirmed by analysts at BTIG Research.
Blue Owl Capital (NYSE:OWL) had its buy rating reissued by analysts at TD Cowen. They currently have a $14.00 price target on the stock.
PDF Solutions (NASDAQ:PDFS) had its buy rating reissued by analysts at DA Davidson. The firm currently has a $56.00 target price on the stock.
ProKidney (NASDAQ:PROK) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $12.00 target price on the stock.
LiveRamp (NYSE:RAMP) had its neutral rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $38.50 price target on the stock, up from their previous price target of $35.00.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its market perform rating reaffirmed by analysts at Leerink Partners. Leerink Partners currently has a $641.00 price target on the stock, down from their previous price target of $792.00.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its neutral rating reiterated by analysts at Citigroup Inc.. They currently have a $700.00 price target on the stock, down from their previous price target of $900.00.
Ralph Lauren (NYSE:RL) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $400.00 target price on the stock.
RS Group (LON:RS1) had its neutral rating reiterated by analysts at UBS Group AG. They currently have a GBX 620 price target on the stock.
Savannah Resources (LON:SAV) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 1,300 price target on the stock.
Standard Life (LON:SDLF) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 870 target price on the stock.
SolarEdge Technologies (NASDAQ:SEDG) had its sell rating reaffirmed by analysts at Glj Research.
The Sage Group (LON:SGE) had its buy rating reaffirmed by analysts at UBS Group AG. They currently have a GBX 1,025 price target on the stock.
SSP Group (LON:SSPG) had its neutral rating reiterated by analysts at UBS Group AG. UBS Group AG currently has a GBX 180 target price on the stock.
Standard Chartered (LON:STAN) had its buy rating reissued by analysts at UBS Group AG. UBS Group AG currently has a GBX 2,130 target price on the stock.
Stewart Information Services (NYSE:STC) had its overweight rating reissued by analysts at Stephens. The firm currently has a $88.00 target price on the stock.
Severn Trent (LON:SVT) had its sell rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a GBX 2,700 target price on the stock.
Tate & Lyle (LON:TATE) had its neutral rating reaffirmed by analysts at UBS Group AG. The firm currently has a GBX 375 target price on the stock.
Texas Roadhouse (NASDAQ:TXRH) had its buy rating reissued by analysts at Guggenheim. They currently have a $210.00 price target on the stock.
Urogen Pharma (NASDAQ:URGN) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $45.00 price target on the stock.
Workday (NASDAQ:WDAY) had its buy rating reiterated by analysts at BTIG Research. They currently have a $175.00 target price on the stock.
York Space Systems (NYSE:YSS) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $33.00 target price on the stock.
Receive News & Ratings for Addus HomeCare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
